Advertisement

Breast Cancer Research and Treatment

, Volume 164, Issue 3, pp 745–745 | Cite as

Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

  • Jessica A. Cintolo-Gonzalez
  • Danielle Braun
  • Amanda L. Blackford
  • Emanuele Mazzola
  • Ahmet Acar
  • Jennifer K. Plichta
  • Molly Griffin
  • Kevin S. Hughes
Erratum
  • 717 Downloads

Erratum to: Breast Cancer Res Treat DOI 10.1007/s10549-017-4247-z

In the paragraphing describing the Tice model, while we do acknowledge that this model was validated in an external cohort from the Mayo Mammography Health Study, an erroneous statement remains in the following paragraph stating “This model has yet to be validated outside its original study population.” As described in the preceding paragraph, this model was validated outside its original study population. Additionally, the creators of the Tice model prefer it to be labeled as the “Breast Cancer Surveillance Consortium (BCSC) model (AKA: Tice model)” rather than label it as Tice model (AKA: Breast Cancer Surveillance Consortium (BCSC) model) given that BCSC is how the model is labeled for the online tool and iphone application.

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Jessica A. Cintolo-Gonzalez
    • 1
  • Danielle Braun
    • 2
    • 3
  • Amanda L. Blackford
    • 4
  • Emanuele Mazzola
    • 3
  • Ahmet Acar
    • 1
  • Jennifer K. Plichta
    • 5
  • Molly Griffin
    • 1
  • Kevin S. Hughes
    • 1
  1. 1.Division of Surgical OncologyMassachusetts General HospitalBostonUSA
  2. 2.Department of BiostatisticsHarvard University T H Chan School of Public HealthBostonUSA
  3. 3.Department of Biostatistics and Computational BiologyDana-Farber Cancer InstituteBostonUSA
  4. 4.Department of OncologyJohns Hopkins University School of MedicineBaltimoreUSA
  5. 5.Duke University Health SystemsDurhamUSA

Personalised recommendations